Tradestie Institutional Equity Comparison Engine

RGNX vs XNCR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XNCR Overall Edge

XNCR Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xencor, Inc. (XNCR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RGNX trades at N/M Forward P/E with -120.4% operating margin (-69.2% YoY revenue) versus XNCR at 68.0x Forward P/E and -72.7% operating margin (+454.9% YoY). In options structure, RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro) against XNCR sits in BREAKOUT (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner XNCR
RGNX N/M vs XNCR 68.0x Fwd P/E
Growth & Margin Winner XNCR
Op Margin -120.4% vs -72.7% ยท YoY -69.2% vs +454.9%
Momentum & Technical Winner XNCR
1Y -35.8% vs +154.6% ยท 52W Pos 19% vs 84%
Options & Structure Winner XNCR
BREAKDOWN (52nd %ile IV) vs BREAKOUT (10th %ile IV)
RGNX NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.47
-2.23% 1D
Market Cap $500.9M
1M Return +7.87%
1Y Return -35.82%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 36.0 Fund 44.0 Flow 69.0 Mom 50.0
XNCR NASDAQ
Xencor, Inc.
Pharmaceutical Preparations
$35.62
-3.98% 1D
Market Cap $2.9B
1M Return +55.86%
1Y Return +154.57%
Forward P/E 68.0x
Unified AI Score
29.6 / 100 SELL
Tech 50.0 Fund 32.0 Flow 66.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RGNX -35.82% XNCR +154.57% Spread: +190.39 pp (XNCR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period RGNX Revenue XNCR Revenue RGNX Op. Margin XNCR Op. Margin Margin Edge
FY2018 $220M $40M 40.3% -195.5% RGNX
FY2019 $40M $160M -422.9% 8.8% XNCR
FY2020 $150M $120M -77.1% -62.6% XNCR
FY2021 $470M $280M 34.0% 15.9% RGNX
FY2022 $110M $160M -233.2% -50.1% XNCR
FY2023 $90M $170M -297.1% -75.8% XNCR
FY2024 $80M $110M -280.0% -161.5% XNCR
FY2025 $170M $130M -94.6% -141.4% RGNX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RGNX (2) vs XNCR (8)
Institutional Metric RGNX XNCR Criterion Row Winner
Market Capitalization Scale $500.9M $2.9B Larger Scale XNCR
Trailing P/E Ratio Valuation N/M 68.0x Lower Multiple XNCR
Forward P/E Ratio Valuation N/M 68.0x Lower Multiple XNCR
Revenue Growth (YoY) Growth -69.2% +454.9% Higher Growth XNCR
Operating Margin (TTM) Profitability -120.4% -72.7% Higher Margin XNCR
Net Profit Margin Profitability -113.9% -58.8% Higher Margin XNCR
Return on Equity (ROE) Capital Efficiency -113.2% -19.9% Higher ROE XNCR
52-Week Range Position Momentum 19% ($5โ€“$16) 84% ($10โ€“$41) Stronger Trend XNCR
Beta / 30D Volatility Risk Regime 1.81ฮฒ ยท 76% Vol 1.19ฮฒ ยท 86% Vol Lower Realized Risk RGNX
Unified Institutional Score Composite Signal 45.3 / 100 (HOLD) 29.6 / 100 (SELL) Higher Composite RGNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RGNX vs XNCR Buy Guide
RGNX BREAKDOWN
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RGNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XNCR BREAKOUT
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live XNCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RGNX nor XNCR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.